Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts.
Marfella R, D'Onofrio N, Mansueto G, Grimaldi V, Trotta MC, Sardu C, Sasso FC, Scisciola L, Amarelli C, Esposito S, D'Amico M, Golino P, De Feo M, Signoriello G, Paolisso P, Gallinoro E, Vanderheyden M, Maiello C, Balestrieri ML, Barbato E, Napoli C, Paolisso G. Marfella R, et al. Among authors: vanderheyden m. Cardiovasc Diabetol. 2022 Aug 5;21(1):146. doi: 10.1186/s12933-022-01573-x. Cardiovasc Diabetol. 2022. PMID: 35932065 Free PMC article. Clinical Trial.
Long-term follow-up after fractional flow reserve-guided treatment strategy in patients with an isolated proximal left anterior descending coronary artery stenosis.
Muller O, Mangiacapra F, Ntalianis A, Verhamme KM, Trana C, Hamilos M, Bartunek J, Vanderheyden M, Wyffels E, Heyndrickx GR, van Rooij FJ, Witteman JC, Hofman A, Wijns W, Barbato E, De Bruyne B. Muller O, et al. Among authors: vanderheyden m. JACC Cardiovasc Interv. 2011 Nov;4(11):1175-82. doi: 10.1016/j.jcin.2011.09.007. Epub 2011 Oct 26. JACC Cardiovasc Interv. 2011. PMID: 22035875 Free article.
Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary revascularization in patients with small-vessel disease.
Puymirat E, Peace A, Mangiacapra F, Conte M, Ntarladimas Y, Bartunek J, Vanderheyden M, Wijns W, De Bruyne B, Barbato E. Puymirat E, et al. Among authors: vanderheyden m. Circ Cardiovasc Interv. 2012 Feb 1;5(1):62-8. doi: 10.1161/CIRCINTERVENTIONS.111.966937. Epub 2012 Feb 7. Circ Cardiovasc Interv. 2012. PMID: 22319067
von Willebrand factor inhibition improves endothelial function in patients with stable angina.
Muller O, Bartunek J, Hamilos M, Berza CT, Mangiacapra F, Ntalianis A, Vercruysse K, Duby C, Wijns W, De Bruyne B, Heyndrickx GR, Vanderheyden M, Holz JB, Barbato E. Muller O, et al. Among authors: vanderheyden m. J Cardiovasc Transl Res. 2013 Jun;6(3):364-70. doi: 10.1007/s12265-012-9422-3. Epub 2012 Dec 12. J Cardiovasc Transl Res. 2013. PMID: 23233321 Clinical Trial.
Long-term clinical outcome after fractional flow reserve- versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts.
Di Serafino L, De Bruyne B, Mangiacapra F, Bartunek J, Agostoni P, Vanderheyden M, Scognamiglio G, Heyndrickx GR, Wijns W, Barbato E. Di Serafino L, et al. Among authors: vanderheyden m. Am Heart J. 2013 Jul;166(1):110-8. doi: 10.1016/j.ahj.2013.04.007. Epub 2013 May 16. Am Heart J. 2013. PMID: 23816029
265 results